Using cost-of-illness methodology applied to a comprehensive survey of 114 daily opiate users not currently in or seeking treatment for their addiction, we estimated the 1996 social costs of untreated opioid dependence in Toronto (Ontario, Canada). The survey collected data on social and demographic characteristics, drug use history, physical and mental health status, the use of health care and substance treatment services, drug use modality and sex-related risks of infectious diseases, sources of income, as well as criminality and involvement with the law enforcement system. The annual social cost generated by this sample, calculated at Canadian $5.086 million, is explained mostly by crime victimization (44.6%) and law enforcement (42.4%), followed by productivity losses (7.0%) and the utilization of health care (6.1%). Applying the $13,100 cost to the estimated 8,000 to 13,000 users and 2.456 million residents living in Toronto yields a range of social cost between $43 and $69 per capita.
on its victims (i.e., crime victimization), from productivity losses, and from drugrelated morbidity and premature mortality, which impairs the well-being of users and affected individuals. 1-3 Cost-of-illness methodology applied to epidemiologic and administrative data (i.e., top-down analysis 4) estimates the 1992 While providing valuable insight into the overall economic burden of illicit drug use, top-down analyses typically 9 include only costs compiled by clinical and administrative information systems (e.g., law enforcement expenditures, but not the broader social costs of crime victimization) 9 cannot distinguish the harm of specific psychoactive substances (e.g., opioids) 9 have limited relevance to the subpopulations generating the greatest social harm (e.g., those dependent on vs. all users of opioids) 9 include both the hidden population of untreated users and those in treatment Similarly, bottom-up estimates of the social costs reported by clients entering treatment (and especially those in therapy) may underestimate the economic burden generated by the hidden population of untreated opioid users to the extent that these diverted or self-selected individuals are healthier, avoid risky drug injection and sex practices, and are better integrated into mainstream society (i.e., stable housing, greater support, more paid work, less criminal activity).
Although the prevalence of lifetime heroin use in the Province of Ontario (Canada) remains low (1.1% during 1996), 7 it is associated with disproportionately high health and social problems. In Vancouver (British Columbia, Canada), overdosing on narcotics has become the leading cause of death among young adults, while the injection of drugs is a leading risk factor of new cases of human immunodeficiency virus (HIV) and viral hepatitis infections, s In Toronto (Ontario, Canada), the percentage of drug-related deaths involving heroin has stabilized at 37%. 9 Heroin-related mortality of 2 per 100,000 residents is comparable to the rate in Minneapolis/St. Paul, Minnesota, but is less than that in Detroit, Michigan, and Philadelphia, Pennsylvania. Through its interrelationship with crime, homelessness, and concurrent mental disorders, dependence on opioids (i.e., natural opiates and substances of synthetic origin) generates substantial social harm. s-l~
To inform better the debate on the social harm of untreated opioid dependence, we estimated the economic burden for Toronto using cost-of-illness methodology applied to data derived from a recent survey of a sample of daily users of natural (opiates) and synthetic origin opioids who were not receiving or seeking treatment. Although cost-of-illness estimates inform policymaking that is concerned with the allocation of health care resources across competing needs and they are used in decision-analysis modeling the cost-effectiveness of alternative interventions, the unique contribution of this bottom-up analysis is the understanding gained about the distribution of the economic burden across health care, law enforcement, and other components of the social harm of opioid dependence.
An assessment of the social harm of untreated opioid dependence needs to consider four dimensions: harm to physical health, harm to mental health, intermediate-level harm to personal and social relationships, and broader harm determined by societal and cultural reaction to drug use. 2~ These dimensions identify key sources and components of the social cost of illicit substance use.
In considering substance abuse as a chronic health condition, it is important to distinguish between the harm of single-occasion use versus the progressive damage derived from chronic untreated dependence. An effective intervention reduces harm in one or more domains.
Direct physical harm mostly arises from isolated events of opioid overdoses, with minimal damage occurring from long-term use. Social costs are generated from the use of health care services, impaired quality of life, and loss of economic productivity. Over the longer term, however, treatment for opioid dependence (and concurrent addictions) may be obtained from public or private agencies.
Hazardous behaviors that impair mental functioning place users and others at risk of harm from accidents in the home, workplace, roadway, and places of recreation. Such events may require health care and law enforcement interventions, impair quality of life, cause death, and reduce economic productivity.
Substantial personal and social harm occurs from infections (HIV, viral hepatitis) from sharing needles and unsafe sex practices. Aside from the high cost of health care and social services, impaired quality of life, and the loss of economic activity, substantial out-of-pocket expenses and support from volunteer agencies may be incurred. Intermediate-level harm from isolated disruption of family and workplace disruptions and longer term impairment of social and economic relationships place users and their victims at risk of injury and social isolation.
The user's lifestyle stresses personal relationships. Aside from mental health effects on users and their families (e.g., depression) from living within the illegal drug culture, the breakdown of personal relationships from these stresses imposes financial and other hardships that may require help from relatives and public agencies. These wider harms may have substantial implications for the use of Although the effect on others and the wider social and cultural harm bearing on users are important, we lack the data to measure, to value, and to attribute these costs to opioid use. Therefore, in this analysis, we focused more narrowly on the social costs of the health care, criminality, and productivity implications of untreated dependence.
There are a number of methodological issues that analysts must consider when estimating the social costs of untreated opioid dependence. These include identifying, measuring, and valuing health care and other resources consumed by drug users, assigning monetary value to foregone economic production from drug-related morbidity and premature mortality, and quantifying the link between drug use and social costs. In our analysis, the recommendations of the international guidelines for estimating the social costs of substance abuse u and the national standards for calculating the cost of health care services 12 were followed.
Although the identification, measurement, and valuation of the consumption of social resources are straightforward conceptually, the accuracy and comprehensiveness of analysis are limited to the data used. Population-based data sources are convenient, but important items are omitted, and the findings may not generalize to certain subgroups (e.g., dependent opioid users). Of particular importance for illicit substance use is that the cost of criminal activity compiled by law enforcement information system is underestimated by the omission of the costs of crime victimization) 3-Is Secondary analysis of survey data, however comprehensive, must also consider methodological issues and data limitations. As for most cost-of-illness studies, the traditional human capital approach 4 was used to estimate productivity losses from opioid-related morbidity and premature mortality. As the human capital assumes labor market equilibrium, full employment, and nonreplacement of individuals lost to the labor force--a situation typically not describing the circumstances of most opioid users~S--the more recent friction-cost method provides a more conservative estimate. 3~ However, to the extent that the labor market conditions and social interventions enhance the employability (participation, retention, wage) of the disadvantaged, both of these methods may understate the potential productivity loss.
Finally, calculating the proportion of social costs attributable t O opioid dependence can be problematic. In contrast to top-down cost-of-illness studies, which use global attributable fractions estimated from epidemiological data, these comprehensive survey data support a more precise analysis. The low participation rate of opioid users in the formal economy, however, raises concerns about the estimation of the time lost to productive activity. In particular, what proportion of these respondents (and the target population) likely will enter into and remain in the formal economy? Similarly, uncertainty exists about the expected reduction in the days that psychoactive substances are used.
METHODS
A recent survey 31 provides a rare opportunity to estimate the economic burden to society of untreated opioid dependence. By the very nature of trying to track individuals engaging in this illegal activity, no formal sampling frame exits for contacting all untreated illicit opioid users in Toronto. Thus, an advertising campaign using flyers posted at needle exchanges and social service agencies was used to recruit subjects. Participants were asked to tell other users about the survey. Given the context of this population, the flyer/snowball recruitment method is the best possible approach that, in spite of its limitation, has demonstrated a high degree of representativeness for hidden populations. 32-34
The sample (n = 114) was interviewed between June 1996 and March 1997.
Eligibility criteria were that subjects had to be daily opiate users currently not in or seeking treatment. Qualified subjects were invited to participate in a oneon-one anonymous and confidential interview after providing informed consent.
Subjects were paid for partaking in the interview of closed-and open-ended questions.
The survey collected data on demographic and socioeconomic characteristics, drug use history, physical and mental health status, use of health care and drug treatment services, modality of drug use, risks of infectious diseases, sources of income, as well as criminality and involvement with the law enforcement system (see Table I for overview and Table II The majority of subjects had been in drug treatment before, many of them more than once. Finally, about half of the sample had been arrested for criminal offenses, half had spent some time in prison, and half were under some form of criminal justice supervision in the past year.
Analysis was concerned with estimating the total economic burden of the study sample of untreated (dependent) opioid users. As such, the sum of the economic activities reported by the respondents was used to estimate social cost (see Activity in Table I ). Cost was calculated as the product of reported activity over 12 months multiplied by the corresponding unit cost and adjusted for the proportion attributable to opioid dependence. Subjects who on average injected a drug at least once a day in last month (n = 106)
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Source: Reference 31. to represent typical (average) activity and were extrapolated to estimate cost for the full year. Economic data reported for other periods were adiusted to 1996 using the consumer price index (for Canada, Ontario, or Toronto, as required).
Analysis was adjusted for missing data using mean (proxy) values calculated from the responding sample (see Activity in Tables III-VI) .
Projecting these findings to the Toronto population, however, should account for the effects of the sample size (see n in Table I ) and response distribution on the precision of point estimates (i.e., mean, median). As the distribution of reported activities is skewed positively, count data with a high proportion of zero responses (i.e., few active respondents; see Active in Table I ), the ~y + %/activity + 1 transformation 35' 36 was employed to estimate the mean point estimate (TMEAN) and its 95% confidence interval (LL, UL) for the cost-items. 37 The means and confidence intervals displayed in the Table I have been converted back from the transformed scale.
RESULTS
To facilitate interpretation of study findings, estimated social costs are reported
in Tables III to VII Tables III-VI) . Social cost is the arithmetic sum of these components (see Table VII ). All costs are in 1996 Canadian dollars.
cost or H~ALTH CARE
The $311,000 cost of health care (Table III) These per diem unit costs, which exclude emergency, outpatient, and long-term care, as well as education and research activities (and corresponding shares of ancillary and overhead expenses), 4~ were adjusted for the intensity of resource utilization. 1228~9 The respective 26% and 23% of inpatient care for physical and mental health attributable to opioid dependence were determined from the predicted annual rates of treated drug overdoses and drug-related attempted suicides, both adjusted for the expected 82% expected reduction in days of drug use (see Cost of Law Enforcement, below). The predicted 10 overdoses and 6 attempted suicides were calculated as reported lifetime incidences standardized for tile period of opioid use.
The $11,900 cost of emergency care was estimated from 323 visits for physical Finally, the $40,000 cost of pharmaceuticals includes prescriptions issued to patients discharged from the hospital following treatment for attempted suicide, drugs prescribed to treat mental health conditions (mostly depression), and prescription drugs diverted for illicit purposes. Costs were estimated using Ontario Drug Formulary prices a7 adjusted for the customary $10.50 pharmacy dispensing fee. Treatment of the 6 attempted suicides (emergency, inpatient, followup care by a psychiatrist) included a small supply of antidepressants (e.g., 10
tablets of Prozac at $1.083 per tablet) provided to cover the period between hospital discharge and psychiatric office care. Also, the 9 respondents who reported chronic drug-related mental health concerns were assumed to take Prozac for the full year (30 tablets per prescription and 12 refills). As above, 23% and 48% of the cost of antidepressants were attributable, respectively, to opioid dependence. Diverted prescriptions (e.g., morphine, oxycodone) are used to finance the purchase of illicit drugs and as a substitute when preferred psychoactive substances are not available. 4a-5~ The $38,800 cost was estimated from the responses of 76 subjects questioned about this activity.* An average cost of $30.80 per prescription (including dispensing fee) was calculated from the reported mix *R. Wall, B. Brands, and J. Blake, The diversion of prescription opioids by a cohort of untreated opiate users, unpublished memo, 1999. of diverted analgesics. Of the cost, 72% was attributed to opioid dependence on the basis of the expected reduction in drug trafficking (see law enforcement discussion below).
COST oF' LAW ENFORCEMENT
The $2,155,000 cost of law enforcement (Table IV) for opioid-related crimes consists of 9 the police costs of investigating incidents, making arrests, and laying charges 9 the court costs of processing charges 9 the correction costs of enforcing sentences These costs were estimated using operating expenses and statistics reported by the Canadian Centre for Justice Statistics.
To distinguish better between drug-related and other criminal activity, reported infractions, arrests, and charges were grouped as follows:
9 possession or use of illicit drugs 9 sale, distribution, or manufacture of illicit drugs (i.e., trafficking) 9 income-related property crimes (shoplifting, minor theft, burglary, theft, breaking and entering, auto theft, robbery, forgery, fraud) 9 other income-related activity (tax evasion, defrauding social assistance, pimping, sex trade) Typical of opioid use behavior, 17~1 most reported criminal activity was for illicit drug possession/use (59%) and income-generating trafficking, property, and other crimes (35%). For arrests, however, while possession/use and incomerelated crimes still accounted for the majority of arrests (13% and 57%, respectively) and charges (12% and 54%, respectively), income-generating property crimes were of particular importance--that is, 9% of the criminal activity was responsible for 54% of the arrests and 51% of the charges.
Among the 94% of survey respondents reporting lifetime arrests, 81% were for infractions committed while using drugs or to obtain money to purchase drugs. Estimating the proportion of criminal activity attributable to opioid-related crime was problematic. Although criminal activity was related to heavy drug use, s2-54 reduction in criminality was determined by the effectiveness of treatment and was limited by prior criminal history (especially that before the onset of drug use). s556 Moreover, sustained change in criminality is mitigated by users' generally poorer health, lower educational attainment, fewer resources, and social stigma that limits their (re)integration into mainstream society, s3
Findings by scientific studies of reduced criminal activity among opioid users in methadone maintenance are encouraging (e.g., the 84% reduction in trafficking and property-related crimeS6), but may be overstated for estimating untreated social costs from the self-selection of subjects into treatment, confounding by rigorous monitoring and sanctions, and the potential for information bias. The study by Johnson and colleagues 51 of the economics of crime among New York
City heroin users provides a more conservative estimate of excess criminal infractions attributable to untreated opioid dependence. As criminal activity is reported by degree of heroin use (daily, regular, irregular), the attributable proportion was estimated as the difference in rates of criminal activity between daily (6 to 7 days per week) and irregular (0 to 2 days per week) users. This calculation assumes that dependent users are unlikely to withdraw completely from using opioids for the rest of their lives (i.e., the chronic disease model), and that in remaining socially disadvantaged, they will continue to engage in incomegenerating crime.
Using the New York data, the 82% between-group (daily vs. irregular) difference in the number of use-days in which psychoactive substances were used is a proxy measure for the reduction in the risk of being arrested and charged for drug possession/use. Similarly, reductions in the rates of income-related crimes (trafficking, property, other) were calculated as between-group differences in self-reported offenses (72%, 48%, 21%, respectively). The risks of committing driving-related and vandalism/loitering/vagrancy infractions were also deemed to diminish with the expected decrease in drug use. The reduction in capital offenses (mostly weapons) was assumed to correspond to the predicted decrease in drug trafficking. In assuming equal risk of violating the terms of probation/ parole, the proportion of law enforcement offenses attributed to opioid dependence was calculated as the weighted average of the above rates. Finally, the proportions of prison, parole, and probation sentences assigned to opioid dependence account for the distribution of charges and patterns of sentencing in Canada. 57
The $1.54 million police cost was calculated using the $2,613 average cost of The $2,267,000 cost of crime victimization (Table V) and the above unit costs of emergency, outpatient, and primary care, including applicable physician fees.
COST OF PRODUCTIVITY LossEs
Untreated opioid dependence is estimated to generate productivity losses of $354,000 (Table VI) . First, respondents' performance of economically valuable paid and volunteered activities is impaired by opioid-related physical and mental health morbidities. Second, periods spent in hospitals, institutions, residential facilities, and prisons reduce the time available for performing such activities.
Third, preoccupation with financing the opioid-related lifestyle detracts many users from meaningful participation in the formal economy. Finally, premature mortality (i.e., before age 65 years) reduces the duration of life in which these activities can be performed. The Ontario minimum wage of $6.85 per hour and a standard working day of 7.5 hours was used to assign monetary value to these losses of productive activities ($51.38 per day). The cost attributable to opioid dependence accounts for the expected 82% reduction in the days of drug use.
The $227,000 cost of opioid-related morbidity was estimated from respondents' report of 6,407 days worked and 469 days volunteered over the past 12 months.
Days worked were compared to the 21,579 potential workdays reported by a comparable sample of Ontario residents 42 and reduced by 55% to correspond to the proportion of untreated (dependent) opioid users most likely to participate in the formal economy, that is, those respondents reporting at least some paid work. This comparator was standardized for demographic (age, sex) structure and adjusted for rates of unemployment and workforce participation. For volunteer activities, more time was provided by the respondents. 42
The $127,000 cost of premature mortality among intravenous drug users was estimated as the earnings generated by the 114 survey respondents as they advance through a series of stages (defined by seven age groupings and two genders) until retiring at the age of 65. 42 Earnings were calculated using prevailing rates of unemployment and labor force participation in these groupings adjusted for a 1% annual growth in productivity and discounted to the present using the 3% rate of time preference. ~ Cost was estimated as the average lifetime earnings foregone due to opioid-related mortality (1% lower rate 66) and mortality related to AIDS (acquired immunodeficiency syndrome) (0.15% among Toronto injection drug users [IDUs]*) reduced by 55% to adjust for the number of respondents most likely to engage in paid work.
*R. S. Remis, M. Millson, and C. Major, The HIV epidemic among injection drug users in Ontario: the situation in 1997, unpublished study, University of Toronto Department of Public Health Sciences, Toronto, Ontario, Canada, 1997.
SAMPLE SOCIAL COST
Of the $5.086 million annual social cost (Table VI) of untreated opioid dependence during 1996 that was estimated for this sample of 114 residents of Toronto, crime victimization explains the largest amount (44.6%), followed by law enforcement (42.4%), productivity losses (7.0%), and, finally, the use of health care (6.1%).
This amount expressed in US currency is $3.730 million. In 1999 Canadian dollars, this cost is $5.307 million ($3.572 million in US dollars).
Consistent with findings of the recent bottom-up British NTORS75 sample variation estimated as standard deviation (see SD in Table I ) was high for most cost-items. Although our smaller sample (n = 114) may explain some variation, comparison to the larger NTORS (n = 1075) suggests that response heterogeneity is characteristic of dependent illicit drug users, with implications for generalizing sample findings to populations. The distributions of survey responses for the cost-items are count data positively skewed, with many respondents reporting zero activity (see Active in Table I ). Also consistent with the NTORS, mean point estimates are larger than the median values, which are generally zero (see mean, median in Table I ). Survey responses confirmed that a set of interrelated activities 25 explains the social cost of untreated opioid dependence (% of survey respondents reporting activity): inpatient (33%), emergency (62%), and office (79%) care for physical health concerns; ambulance use for drug overdoses (32%) and attempted suicides (28%); diversion of prescriptions (42%); income-related property victimizations (38%), arrests (36%), and charges (38%); imprisonment (42%); and no paid work over the past 12 months (45%).
GENERALIZATION OF SAMPLE SOCIAL COSTS TO THE TORONTO POPULATION
In the absence of other samples of untreated illicit opioid users in Toronto and elsewhere, assessing the external validity of samples drawn from hidden populations is problematic. Comparison to other North American surveys of illicit drug users finds that our respondents exhibited and confirmed relevant demographics and socioeconomic characteristics, history and profile of illicit drug use, health status and health risks, as well as involvement with criminal justice system. 67-7~ One major caveat limiting the generalization of our findings, however, is that most respondents were recruited within the context of needle exchanges and social service agencies. To the extent that these users are informed better about risks to their health and better motivated to access health/social services, their social costs may be lower compared to otherwise similar but more isolated individuals. Overall, we believe that these data provide valuable insights into a typical sample of these less-isolated untreated (dependent) opioid users.
The $105-$171 million range of the social cost of untreated opioid use and the corresponding $43 to $69 spread in the economic burden per capita was estimated for Toronto (2.456 million residents, 9 8,000 to 13,000 untreated users) using the expected $13,100 per user estimated from the mean of the transformed data of the cost-items accounting for uncertainty in the estimated number of opioid users (10,000 to 15,00031-n) and the proportion not in methadone maintenance (80% to 85%).* In contrast to the sample, law enforcement (39.1%) and productivity losses (33.2%) explain the greatest proportions of social cost, followed by crime victimization (21.2%) and health care (6.6%).
SENSITIVITY ANALYSIS
Analysis is sensitive to the precision of estimated statistics for the model costitems, the set of items used, and uncertainty in the specification of model parameters. Social cost is also sensitive to assumptions made about crime victimization, out-of-pocket costs, productivity losses, and the expected reduction in the days of drug use.
The 95% confidence intervals estimated for means of the cost-items (see LL, UL in Table I) The proportion of criminal activity attributable to untreated opioid dependence estimated here from between-group differences in the activities of New
York City daily and irregular heroin users appear to be a reasonable proxy measure for the City of Toronto. The proportion of overall illicit drug-related criminality (possession/use, trafficking, property, and other income-related infractions) is similar to the 81% reported by the survey respondents and comparable across US areas, regardless of differences in samples of users, settings, and data collection methods, sl Also, the 48% difference in property crime is very similar to the 49% decline following the introduction of prescription heroin in the recent Swiss trial. ~4 Moreover, the difference in income-related criminality (trafficking, property, and other income-related crimes) is remarkably similar to the amount that the survey respondents report they would eliminate if heroin were provided to them (62.6% vs. 62.9%). Finally, the predicted 82% reduction in days of drug consumption between daily and irregular drug users is compara- to pass these expenses on to paying customers, the burden of retail victimization is distributed in complex ways across society, and estimation of its economic cost is correspondingly more difficult. In the absence of more accurate data, out-of-pocket expense is a conservative proxy measure of the economic cost of household/personal crime victimization.
The victim compensation approach used here to assign monetary value to crime victims' pain and suffering is more consistent than jury-based awards as it better reflects society's willingness to pay to prevent crime. Unfortunately, we have no data sources from which to estimate the monetary value of the pain and suffering of opioid users and their family/friends. However, a recent exercise assumed that users or their friends/family would be willing to pay US $10,000
(Can $15,000) to avoid 1 year of the day-to-day suffering caused by drug addictinny The 85% underernployment among survey respondents is comparable to rates reported elsewhere) z' 22 For this sample, 45% reported no paid work over the past 12 months. Among those reporting paid work, however, respondents were not active throughout the year (an average of 27.7 weeks worked per year), but they worked full time when employed (an average of 4.9 days worked per week).
More respondents reported volunteering than the general Ontario population (25% vs. 16%). Compared to the general population, differences in paid and nonpaid activities reflect personal choice, stigma, and other barriers to obtaining employment, as well as performing mandated community service.
As to the amount of economic productivity lost through opioid dependence, Significant in interpreting the results of this study is that, of the $311,000 health care cost attributable to opioid dependence, 42% is devoted to substance abuse treatment. This imbalance highlights the need to develop a more coordinated delivery of health care services in response to the problem of illicit drug use, encompassing screening to treatment options that cost-effectively engage and retain users in therapeutic relationships. Moreover, for treating users for whom substitution is not viable because of compliance and acceptability issues, other options should be considered. 8 Only then will the health care system costeffectively allocate resources to reducing the burden of opioid dependence on both users and society. Clearly, further research is needed to increase our knowledge on how to reduce the social harm and derived cost of untreated opioid dependence effectively and appropriately.
